Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?

[1]  M. Pocard,et al.  Standardizing training for Pressurized Intraperitoneal Aerosol Chemotherapy. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  J. Fontaine,et al.  Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis , 2020, Histopathology.

[3]  J. Torkington,et al.  Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework , 2020, BJS open.

[4]  S. Detlefsen,et al.  Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  M. Hübner,et al.  Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. , 2019, The Lancet. Oncology.

[6]  B. Goh,et al.  PIPAC paclitaxel: A systematic and peritoneal tissue pharmacokinetic study in swine. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  P. Pattyn,et al.  Safety and preliminary efficacy of electrostatic precipitation during pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable carcinomatosis. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  M. Pocard,et al.  Pleura and Peritoneum , 2019 .

[9]  C. Sempoux,et al.  Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis , 2019, Histopathology.

[10]  S. Kruijff,et al.  Delta Peritoneal Cancer Index (ΔPCI): a new dynamic prognostic parameter for survival in patients with peritoneal carcinomatosis from colorectal cancer , 2019, European Journal of Surgical Oncology.

[11]  M. Pocard,et al.  Oxaliplatin use in pressurized intraperitoneal aerosole chemotherapy(PIPAC) is safe and well tolerated: a multicenter study , 2019, European Journal of Surgical Oncology.

[12]  S. Ndaw,et al.  Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination. , 2018, Toxicology letters.

[13]  M. Schwab,et al.  Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer , 2018, Journal of clinical medicine.

[14]  D. Nowak,et al.  Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)? , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  M. Pocard,et al.  Pleura and Peritoneum , 2018 .

[16]  C. Tempfer,et al.  How to Perform Safe and Technically Optimized Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Experience After a Consecutive Series of 1200 Procedures , 2018, Journal of Gastrointestinal Surgery.

[17]  C. Tempfer,et al.  A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. , 2018, Gynecologic oncology.

[18]  D. Pezet,et al.  Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  M. Pocard,et al.  Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study. , 2018, Pleura and Peritoneum.

[20]  M. Pocard,et al.  PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study , 2018, Pleura and peritoneum.

[21]  D. Elias,et al.  Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG‐RENAPE) , 2018, The British journal of surgery.

[22]  O. Sgarbura,et al.  Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  A. Dohan,et al.  Evaluation of the peritoneal carcinomatosis index with CT and MRI , 2017, The British journal of surgery.

[24]  N. Demartines,et al.  Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  N. Demartines,et al.  Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis , 2017, The British journal of surgery.

[26]  M. Vaira,et al.  Single-port access for Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): technique, feasibility and safety , 2016, Pleura and peritoneum.

[27]  Urs Giger-Pabst,et al.  Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy , 2013, Annals of Surgical Oncology.

[28]  W. Solass,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.

[29]  David W. Taggart,et al.  No surgical innovation without evaluation: the IDEAL recommendations , 2009, The Lancet.

[30]  S. Lang,et al.  Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomen. , 2019, Pleura and Peritoneum.